81 completed, 11 unknown, 8 terminated, 3 withdrawn. 109 Phase 2, 16 Phase 3, 13 Phase 1.
Follow Fibromyalgia: new trials by email Literature Review of Fibromyalgia trials Research Report on Fibromyalgia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Full-Spectrum Cannabis Extract for Chronic Pain and Bone Health Biomarkers in Women Full-Spectrum Cannabis Extract 5:1 (CBD:THC) - Chronic Pain, Fibromyalgia | Phase 2 | Not yet recruiting | Associação Pan-Americana Multidisciplinar de Endocanabinologia | 80 | 2026-09-01 | 2026-08-26 |
| Effects of Curcumin-Piperine Supplementation in Fibromyalgia Curcumin - Piperine, Placebo - Fibromyalgia (FM) | Phase 2 | Not yet recruiting | Ain Shams University | 80 | 2026-08-01 | 2026-08-11 |
| Phase II Clinical Trial: Multi-dosing the BCG Vaccine for Fibromyalgia Bacillus Calmette Guerin Vaccine, Saline Injection - Fibromyalgia | Phase 2 | Withdrawn | Massachusetts General Hospital | 2026-01-01 | 2024-11-21 | |
| EFFECTS OF A FULL SPECTRUM CANNABIS EXTRACT WITH DIFFERENT DOSES OF CBD AND THC ON THE MODULATION OF FIBROMYALGIA: A PILOT, MULTICENTER, OPEN LABEL CLINICAL TRIAL (FRIDINHA) Cannabis - Fibromyalgia | Phase 1 / Phase 2 | Active not recruiting | Federal University of Latin American Integration | 36 | 2025-09-15 | 2026-03-27 |
| Ultrasound-Guided Stellate Ganglion Block in Fibromyalgia Lidocaine and Dexamethasone, Normal Saline - Fibromyalgia | Phase 2 / Phase 3 | Completed | Sanliurfa Education and Research Hospital | 68 | 2025-06-01 | 2026-01-16 |
| A Clinical Study of ONO-1110 in Patients With Fibromyalgia ONO-1110, Placebo - Fibromyalgia | Phase 2 | Completed | Ono Pharmaceutical Co., Ltd. | 175 | 2025-03-26 | 2026-07-07 |
| Lidocaine Versus Magnesium Sulphate in Management of Myofascial Pain Dysfunction Syndrome Magnesium sulphate, Lidocaine (drug), Saline - Myofascial Pain Dysfunction Syndrome | Phase 2 | Unknown | Misr University for Science and Technology | 75 | 2024-10-01 | 2024-09-19 |
| Biosignature of the Response to Treatment With Cannabis Oil in Individuals With Fibromyalgia Cannabis Oil (5% THC/5% CBD), Sham Cannabis Oil - Fibromyalgia | Phase 2 | Recruiting | Rambam Health Care Campus | 150 | 2024-05-30 | 2025-04-27 |
| Fecal Microbiome Transplantation From Healthy Donors to Individuals With Fibromyalgia Fecal Microbiome Transplantation, Sham Fecal Microbiome Transplantation - Fibromyalgia | Phase 2 | Enrolling by invitation | Rambam Health Care Campus | 100 | 2024-03-11 | 2024-05-21 |
| Open-label Study to Assess the Safety and Efficacy of Psilocybin With Psychotherapy in Adult Participants With Fibromyalgia Psilocybin, Psychotherapy - Fibromyalgia | Phase 2 | Completed | Kevin Boehnke | 17 | 2023-09-27 | 2025-04-16 |
| Metformin for Fibromyalgia Symptoms (INFORM Trial) Metformin, Placebo - Fibromyalgia Syndrome | Phase 2 | Recruiting | University of Utah | 72 | 2023-04-01 | 2026-03-30 |
| A Proof-of-concept Study to Evaluate the Efficacy and Safety of Rozanolixizumab to Treat Adult Study Participants With Severe Fibromyalgia Syndrome rozanolixizumab, Placebo - Fibromyalgia | Phase 2 | Completed | UCB Biopharma SRL | 63 | 2022-12-21 | 2025-07-01 |
| iTBS-DCS in Fibromyalgia D-Cycloserine, Placebo oral tablet, iTBS repetitive Transcranial Magnetic Stimulation (rTMS) - Fibromyalgia | Phase 2 | Terminated | University of Calgary | 47 | 2022-08-29 | 2025-08-17 |
| CBD (Cannabidiol)/THC (Tetrahydrocannabinol) Solution as a Pharmacological Strategy for Patients With Fibromyalgia (FibroCann) cannabidiol and tetrahydrocannabinol, Placebo - Fibromyalgia | Phase 2 / Phase 3 | Unknown | FG Brasil LTDA | 40 | 2022-04-15 | 2022-04-11 |
| Reconsolidation Therapy With Propranolol as a Treatment for Chronic Pain Propranolol Hydrochloride, Placebo, Reactivation procedure - Chronic Low-back Pain, Fibromyalgia | Phase 2 | Completed | Université de Sherbrooke | 48 | 2022-02-07 | 2025-09-26 |
| Neuromodulatory Effects of Transcranial Pulsed Current Stimulation in Fibromyalgia Transcranial Pulsed Current Stimulation - Fibromyalgia | Phase 2 | Unknown | Centro Universitario La Salle | 70 | 2021-12-10 | 2022-04-11 |
| The Effect of Minocycline and N-acetylcysteine for the Treatment of Fibromyalgia minocycline (200 mg daily) and NAC (1200 mg daily) followed by placebo, Placebo followed by minocycline (200 mg daily) and NAC (1200 mg daily) - Fibromyalgia | Phase 1 / Phase 2 | Completed | Medical University of South Carolina | 14 | 2021-12-06 | 2024-01-30 |
| Nitrous Oxide as Treatment for Fibromyalgia Nitrous oxide gas for inhalation, Placebo - Fibromyalgia, Central Neuropathic Pain | Phase 2 | Withdrawn | University of Chicago | 2021-11-12 | 2026-05-14 | |
| Impact of Post-Traumatic Stress Disorder Treatment by Reconsolidation Therapy on Fibromyalgia Syndrome Propranolol - Fibromyalgia Syndrome, Posttraumatic Stress Disorder | Phase 2 | Completed | Centre Hospitalier Henri Laborit | 17 | 2021-08-13 | 2026-09-09 |
| Fibromyalgia Outcome Research Trial Evaluating Synergistic Suppression of HSV-1 IMC-1, Placebo BID Tablet - Fibromyalgia | Phase 2 | Completed | Virios Therapeutics, Inc. | 422 | 2021-06-03 | 2022-09-27 |
Showing 20 of 109. Sign in to see all of them.
Pain (20) · Chronic Pain (18) · Fatigue (6) · Motor Activity (6) · Fatigue Syndrome, Chronic (4) · Depression (3) · Agnosia (2) · Anxiety Disorders (2) · Back Pain (2) · Irritable Bowel Syndrome (2) · Marijuana Abuse (2) · Migraine Disorders (2) · Myalgia (2) · Sleep Initiation and Maintenance Disorders (2)
Nervous System Diseases (109) · Neuromuscular Diseases (109) · Rheumatic Diseases (109) · Muscular Diseases (108) · Musculoskeletal Diseases (108) · Pathological Conditions, Signs and Symptoms (45) · Signs and Symptoms (43) · Neurologic Manifestations (41) · Pain (20) · Behavior (11) · Mental Disorders (7) · Pathologic Processes (7) · Central Nervous System Diseases (5) · Chronic Disease (5) · Disease Attributes (5)
Exercise (5) · Milnacipran (5) · Transcranial Direct Current Stimulation (5) · Amitriptyline (3) · Duloxetine Hydrochloride (3) · Pregabalin (3) · Sodium Chloride (3) · Control Groups (2) · Dronabinol (2) · Escitalopram (2) · Lidocaine (2) · Metformin (2) · Mirtazapine (2) · NYX-2925 (2) · Naltrexone (2)
National Center for Complementary and Integrative Health (NCCIH) (4) · Hospital de Clinicas de Porto Alegre (3) · University of Michigan (3) · University of Washington (3) · Wyeth is now a wholly owned subsidiary of Pfizer (3) · Aptinyx (2) · Astellas Pharma Global Development, Inc. (2) · Centro Universitario La Salle (2) · Duke University (2) · Federal University of São Paulo (2) · Forest Laboratories (2) · Rambam Health Care Campus (2) · UCB Pharma (2) · University Hospital, Antwerp (2) · University of Alabama at Birmingham (2)
United States (61) · Brazil (9) · Canada (6) · United Kingdom (5) · Belgium (3) · France (3) · Israel (3) · Spain (3) · Denmark (2) · Germany (2) · Sweden (2) · Switzerland (2) · Australia (1) · Egypt (1) · Finland (1)
Akiko Okifuji, PhD (2) · Amir Minerbi, MD-PhD (2) · Dennis C. Turk, PhD (2) · Mark Plazier, M.D. (2) · Patricia M D'Astoli, LPN (2) · Wolnei Caumo, MD, PhD (2) · Ajay Wasan, MD, MSc (1) · Albert Nadal, MD (1) · Alexander McGirr, MD, PhD (1) · Alexandre DaSilva, DDS, MS (1) · Andrea H Kayo, PT (1) · Andrea Nackley, PhD (1)
PMID 26112278, PMID 11764222, PMID 15556826, PMID 15943960, PMID 17133529, PMID 18053120, PMID 18311814, PMID 18821656, PMID 19250003, PMID 19369473, PMID 20828282, PMID 21594719, PMID 21772818, PMID 22336292, PMID 23618477, PMID 24251273, PMID 24868587, PMID 25052847, PMID 25371383, PMID 25660434, PMID 25873248, PMID 26335989, PMID 29149437, PMID 29870396, PMID 30127596, PMID 30419855, PMID 30510505, PMID 32131045, PMID 32856281, PMID 33328761, PMID 34781989, PMID 35526605, PMID 36269028, PMID 36715655, PMID 36997252, PMID 37382794, PMID 38258677, PMID 40171515, PMID 41595724, PMID 42162266, PMID 42431386, PMID 42530408, PMID 42748952, PMID 42830128, PMID 42857927
R01AR044724 (2), 2019 (1), K01AT001111 (1), P50AT000084 (1), R01AR044020 (1), R01AR044064 (1), R01AR048888 (1), R01AR050044 (1), R01AR052368 (1), R01HD096331 (1), R01NR008150 (1), R21AR053963 (1), R21AR082574 (1), UG3AR076568 (1)